Teladoc Health, Inc. earnings per share and revenue
On 29 de out. de 2025, TDOC reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.27 USD, resulting in a -3.17% surprise. Revenue reached 626.44 milhão, compared to an expected 638.43 milhão, with a -1.88% difference. The market reacted with a +6.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 28 analistas forecast an EPS of -0.19 USD, with revenue projected to reach 647.68 milhão USD, implying an diminuir of -32.14% EPS, and aumentar of 3.39% in Revenue from the last quarter.
FAQ
What were Teladoc Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Teladoc Health, Inc. reported EPS of -$0.28, missing estimates by -3.17%, and revenue of $626.44M, -1.88% below expectations.
How did the market react to Teladoc Health, Inc.'s Q3 2025 earnings?
The stock price moved up 6.2%, changed from $8.23 before the earnings release to $8.74 the day after.
When is Teladoc Health, Inc. expected to report next?
The next earning report is scheduled for 24 de fev. de 2026.
What are the forecasts for Teladoc Health, Inc.'s next earnings report?
Based on 28
analistas, Teladoc Health, Inc. is expected to report EPS of -$0.19 and revenue of $647.68M for Q4 2025.